Breaking News Instant updates and real-time market news.

WLTW

Willis Towers Watson

$178.33

1.87 (1.06%)

, MSFT

Microsoft

$126.90

0.71 (0.56%)

09:14
05/22/19
05/22
09:14
05/22/19
09:14

Willis Towers Watson announces quantum computing collaboration with Microsoft

Willis Towers Watson (WLTW) announced an exclusive deal with Microsoft (MSFT) to develop the potential of quantum computing for its risk management and insurance clients within the financial services, insurance and investment space. Willis Towers Watson has a long-standing partnership with Microsoft, focused on the development of technology and bringing advanced modelling tools to insurers. This latest announcement is an extension of that partnership and offers the potential to transform risk quantification and make the insurance value chain more efficient.

WLTW

Willis Towers Watson

$178.33

1.87 (1.06%)

MSFT

Microsoft

$126.90

0.71 (0.56%)

  • 22

    May

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 11

    Jun

  • 19

    Jun

  • 23

    Jun

  • 06

    Aug

WLTW Willis Towers Watson
$178.33

1.87 (1.06%)

04/02/19
SBSH
04/02/19
NO CHANGE
Target $200
SBSH
Buy
Willis Towers Watson price target raised to $200 from $192 at Citi
Citi analyst James Naklicki raised his price target for Willis Towers Watson to $200 from $192 saying he has a favorable view of the company's Tranzact acquisition. Tranzact is highly levered to the "rapidly growing" Medicare Advantage and Medicare Supplemental market, Naklicki tells investors in a research note. He keeps a Buy rating on Willis Towers Watson.
04/08/19
MKMP
04/08/19
NO CHANGE
Target $210
MKMP
Buy
Willis Towers Watson price target raised to $210 from $190 at MKM Partners
MKM Partners analyst Harry Fong raised his price target on Willis Towers Watson to $210and kept his Buy rating after its latest TRANZACT acquisition, saying the deal positions the company for two new Health Reimbursement Arrangements to be launched in the next two years. The analyst notes that TRANZACT will "enhance Willis's capabilities in the direct-to-consumer channel with Medicare and other products", complementing the company's Liazon and Extend Health units facilitating transition from group health plan due to retirement into a Medicare plan. Fong also states that while Medicare business grows at a low single-digit rate, the potential growth rate for the individual HRA business could be "significantly higher."
04/08/19
RBCM
04/08/19
NO CHANGE
RBCM
Outperform
eHealth guidance still 'looks conservative', says RBC Capital
RBC Capital analyst Frank Morgan kept his Outperform rating on eHealth (EHTH), stating that its valuation is supported by the $1.4B deal by WillisTowers Watson (WLTW) to acquire Tranzact which is also validating his bullish MA thesis. The analyst also notes that the stock has performed well in an otherwise "difficult healthcare tape", in part because of its "strong growth prospects in a niche not perceived as a problem with the healthcare system."
04/17/19
RHCO
04/17/19
NO CHANGE
RHCO
Buy
eHealth pullback presents 'very attractive' entry point, says SunTrust
SunTrust analyst Tobey Sommer said he views the mid-teen percentage decline in eHealth (EHTH) shares amid worries about Medicare for all proposals as presenting a "very attractive" entry point, noting that applying the same multiple paid by Willis Towers Watson (WLTW) for Tranzact implies a $62 share price for eHealth. While eHealth has a lower EBITDA margin, its revenue is growing faster and it has exposure in the individual and small business markets as well as the main Medicare business. The analyst, who believes eHealth's multi-year top-line growth outlook is substantially superior to consensus forecasts, driven by superior Medicare growth, keeps a Buy rating on the shares.
MSFT Microsoft
$126.90

0.71 (0.56%)

05/17/19
CHLM
05/17/19
DOWNGRADE
CHLM
Hold
Craig-Hallum downgrades Cray to Hold, but says bidding war possible
Craig-Hallum analyst Chad Bennett downgrade Cray (CRAY) to Hold from Buy after the company announced a deal to be acquired by HP Enterprise (HPE) for $35 per share, but he added that he thinks a bidding war is possible since he doesn't believe the stock buyout price "has even begun to value" Cray's proprietary interconnect technology and its modular software stack for next generation AI/ML workloads. He believes there could be a number of interested parties in Cray including Microsoft (MSFT), Dell (DELL), Intel (INTC), Google (GOOG), Amazon (AMZN) and potentially IBM (IBM).
05/20/19
UBSW
05/20/19
NO CHANGE
Target $150
UBSW
Buy
Microsoft's Azure adoption proceeding well, says UBS
UBS analyst Jennifer Lowe kept her Buy rating and $150 price target on Microsoft after meeting with its Investor Relations executives last week, saying the discussions affirmed her view that adoption of the company's Azure is going well. The analyst expects Microsoft's margins to "work higher", adding that she is also positive on the company's growth prospects around Office 365 and cloud gaming. Lowe expects Microsoft to hold its current enterpise value to free cash flow multiple amid underlying growth in spite of the company investing more in its growth initiatives.
05/20/19
CHLM
05/20/19
DOWNGRADE
Target $35
CHLM
Hold
Cray downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Chad Bennett downgraded Cray (CRAY) to Hold from Buy and lowered his price target on the shares to $35 from $36 after HP Enterprise (HPE) announced that it has entered into an agreement to purchase the company for $35.00 per share in cash, totaling $1.3B net of cash. The analyst believes the possibility of another buyer coming in over the top is fairly low, but notes that the price is "too low" based on the opportunities Cray has in front of it over the next few years. Furthermore, Bennett believes there would be a number of interested parties in Cray including Microsoft (MSFT), Dell (DELL), Intel (INTC), Alphabet (GOOG), Amazon (AMZN), and potentially IBM (IBM).
05/22/19
OPCO
05/22/19
NO CHANGE
Target $145
OPCO
Outperform
Microsoft restructured itself around intelligent edge cloud, says Oppenheimer
After attending the Microsoft Build Developer Conference, Oppenheimer analyst Timothy Horan notes it became obvious that the company has totally restructured itself around the intelligent edge cloud. Microsoft sees Azure as a base layer that customers use to run their applications on top of but also as a building block for its services up the software "stack" through dozens of new PaaS and SaaS offerings, he contends. The analyst adds that by running on Azure, Microsoft applications become cheaper to operate, easier to innovate, and integrate the services. He reiterates an Outperform rating and $145 price target on the shares.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.